表紙
市場調查報告書
商品編碼
1063201

細胞離解的全球市場:2021∼2028年

Global Cell Dissociation Market - 2021-2028

出版日期: | 出版商: DataM Intelligence | 英文 175 Pages | 商品交期: 約2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球細胞離解市場相關調查分析,市場動態,COVID-19分析,各產品類型、組織、終端用戶、地區市場分析,競爭情形,企業簡介等資訊。

目錄

第1章 全球細胞離解市場調查手法和範圍

  • 調查手法
  • 調查的目的和調查範圍

第2章 全球細胞離解市場-市場定義和概要

第3章 全球細胞離解市場-摘要整理

  • 市場明細:各產品類型
  • 市場明細:各組織
  • 市場明細:各終端用戶
  • 市場明細:各地區

第4章 全球細胞離解市場-市場動態

  • 影響市場的要素
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 影響分析

第5章 全球細胞離解市場-產業分析

  • 供應鏈分析
  • 價格分析
  • 法規分析
  • 未支援需求

第6章 全球細胞離解市場-COVID-19分析

  • 市場上市的COVID-19分析
    • COVID-19前的市場上的情境
    • COVID-19目前市場情境
    • COVID-19後或未來情境
  • COVID-19的價格動態
  • 需求與供給的頻譜
  • 大流行時的市場相關的政府的舉措
  • 製造商策略性舉措
  • 結論

第7章 全球細胞離解市場-各產品類型

  • 簡介
    • 市場規模分析,及與前一年同期比較成長率分析(%):各產品類型
    • 市場魅力指數:產品類型各市場區隔
  • 酵素分解生成物
    • 膠原酵素
    • 胰蛋白酶
    • 木瓜蛋白酶
    • 彈性蛋白酶
    • 脫氧核糖核酸酶
    • 玻糖醛酸酶
    • 其他
    • 簡介
    • 市場規模分析((100萬美元)2019∼2028年)及與前一年同期比較成長率分析(%)(2020∼2028年)
  • 非酵素的離解生成物
  • 設備和配件

第8章 全球細胞離解市場-各組織

  • 簡介
    • 市場規模分析,及與前一年同期比較成長率分析(%):各組織
    • 市場魅力指數:各組織市場區隔
  • 結締組織
    • 簡介
    • 市場規模分析((100萬美元)2019∼2028年)及與前一年同期比較成長率分析(%)(2020∼2028年)
  • 表皮組織
  • 其他

第9章 全球細胞離解市場-各終端用戶

  • 簡介
    • 市場規模分析,及與前一年同期比較成長率分析(%):各終端用戶
    • 市場魅力指數:各終端用戶市場區隔
  • 製藥及生物科技企業
    • 簡介
    • 市場規模分析((100萬美元)2019∼2028年)及與前一年同期比較成長率分析(%)(2020∼2028年)
  • 調查及學術機構
  • 其他

第10章 全球細胞離解市場-各地區

  • 簡介
    • 市場規模分析((100萬美元)2019∼2028年)及與前一年同期比較成長率分析(%)(2020∼2028年):各地區
    • 市場魅力指數:各地區
  • 北美
  • 歐洲
  • 南美
  • 亞太地區
  • 中東和非洲

第11章 全球細胞離解市場-競爭情形

  • 主要的發展與策略
  • 企業佔有率分析
  • 產品的基準
  • 值得注意的主要企業的清單

第12章 全球細胞離解市場-企業簡介

  • Merck KGaA
  • Thermo Fisher Scientific
  • Becton, Dickinson and Company
  • F. Hoffmann-La Roche Ltd.
  • Miltenyi Biotec
  • PromoCell GmbH
  • AcceGen
  • Capricorn Scientific
  • Neuromics
  • Genlantis

第13章 全球細胞離解市場-DataM

目錄
Product Code: DMBT4827

Market Overview

The global cell dissociation market size was valued US$ XX million in 2020 and is estimated to reach US$ XX million by 2028, growing at a CAGR of XX % during the forecast period (2021-2028).

The cell dissociation process is also called Trypsinization. With the help of proteolytic enzymes, the adhering cell is separated from the surface or substrate. Cell dissociation cushions, which detach cell lines and tissues from containers' plastic or glass surfaces for increasing isolation efficacy with high cell practicality, have collagenolytic and proteolytic properties.

Market Dynamics

The increasing R&D activities in biopharmaceutical companies are expected to drive market growth.

The biopharmaceutical industry's major firms are focusing on R&D in various therapeutic areas to bring novel pharmaceuticals to market. These businesses are doing so by investing substantially in clinical trials, efficacy studies, and toxicity studies, among other things. The vast majority of this research utilizes tissue dissociation products to isolate cells from primary tissues. For instance, The pharmaceutical sector spent $83 billion on research and development in 2019. Compared to the preceding decade, the number of new pharmaceuticals licensed for sale increased by 60% between 2010 and 2019, reaching a high of 59 new drugs approved in 2018.

Moreover, America's biopharmaceutical companies are committed to advancing personalized medicines. A recent industry survey revealed that 42% of new medicines in the pipeline could be personalized medicines. Additionally, Researchers and scientists are building on a huge body of knowledge that has gathered through time as they examine novel substances, illuminating illness pathways and providing insight into the best medication targets. Thus, the market is expected to drive in the forecast period.

Restraint:

The high cost of tissue and cell-based procedures, enzyme-free dissociation products are preferred over enzymatic dissociation products, ethical limits and concerns about the use of cell-based research and lack of infrastructure for cell-based research in developing regions are some of the factors due to which the market is expected to get hampered in the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic has moderately impacted healthcare systems and the market. The pandemic has provided crucial growth prospects. The amount of research and development to study and evaluate the virus that triggered the pandemic has doubled. Therefore, the market is likely to grow faster in developed nations with many research organizations. Countries in the Asia Pacific and other emerging regions, on the other hand, have increased their research on the new coronavirus.

In contrast, the COVID-19 pandemic has had a substantial impact on hospital resources worldwide. It has largely been accomplished by drastically lowering inpatient and outpatient services for various diseases and instituting infection prevention and control methods. The frequency of cancer screening and diagnostic treatments dropped dramatically, with the epidemic affecting countries worldwide. Thus, the market will undergo impetus growth during the forecast period.

Segment Analysis

Enzymatic Dissociation Products segment is expected to hold the largest market share in cell dissociation market

The enzymatic dissociation products segment is expected to dominate in 2020. Enzymatic dissociation is a method of disaggregating cell culture samples using particular proteins. The procedure uses enzymes such as trypsin and collagenase to break down tissue and release the target cells. The tissue type determines the enzyme used, and finding the optimum mix produces the best results. Moreover, enzymes are used in stem cell research and cell biology investigations for cell and tissue dissociation, primary cell separation, and single-cell harvesting. The employment of enzymes for cell dissociation is very common. Any dissociation procedure aims to get as many functionally viable dissociated cells as possible. The kind of tissue, age of the animal/human, dissociation media utilized, an enzyme used, enzyme concentration, temperature, and genetic alterations all influence the outcome of any dissociation operation. As a result, numerous enzymes are used in research for various applications. Trypsin, collagenase, elastase, and hyaluronidase are among the most commonly employed enzymatic dissociation products in decreasing the frequency of use. Thus, the market segment is expected to boost in the forecast period from the above statements.

Geographical Analysis

North America region holds the largest market share in the global cell dissociation market

In 2020, North America accounted for the highest revenue share. Sustained expansion in the pharmaceutical and biotechnology sectors, rising cancer and other chronic illness incidences, and a strong trend of R&D investments in life sciences by industry and academia, acquisition and collaboration by the key players in the region are some of the factors due to which the market is expected to boost in the forecast period. For instance, according to the American Cancer Society, in 2021, 1,898,160 new cancer cases and 608,570 cancer deaths are projected to occur in the United States. In contrast, in 2020, an estimated 1,806,590 new cancer cases were diagnosed in the United States, and 606,520 people died from the disease. The three most common cancers for women are breast, lung, and colorectal, and they will account for an estimated 50% of all new cancer diagnoses in 2020.

Moreover, in 2020, Thermo Fisher Scientific extended its strategic relationship with Symphogen (Denmark) to promote biopharmaceutical discovery and development. Thermo Fisher Scientific acquired QIAGEN N.V. (Germany) to extend its Specialty Diagnostics range. Therefore, it has increased the demand for cell dissociation products in the region. Thus, the North American region is expected to hold the largest market share in the forecast period from the above statements.

Competitive Landscape

Major key players in the cell dissociation market are: Merck KGaA, Thermo Fisher Scientific, Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Miltenyi Biotec, PromoCell GmbH, AcceGen, Capricorn Scientific, Neuromics and Genlantis.

Thermo Fisher Scientific:

Overview:

Thermo Fisher Scientific is an American company incorporated in 1956 and is based in Waltham, Massachusetts. The company offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and services worldwide. Moreover, the global team has more than 90,000 colleagues who deliver an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon.

Product Portfolio:

Gibco: Gibco Cell Dissociation Buffer is a membrane-filtered, isotonic, and enzyme-free solution of salts, chelating agents, and cell-conditioning agents in calcium-free and magnesium-free phosphate-buffered saline (PBS).

Why Purchase the Report?

  • Visualize the composition of the cell dissociation market segmentation by product type, tissue, end user and region highlighting the key commercial assets and players.
  • Identify commercial opportunities in cell dissociation market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of cell dissociation market- level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global cell dissociation market report would provide an access to an approx. 45+ market data table, 40+ figures and 175 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Market Segmentation

Global Cell Dissociation Market - By Product Type

  • Enzymatic Dissociation Products
  • Collagenase
  • Trypsin
  • Papain
  • Elastase
  • DNase
  • Hyaluronidase
  • Others
  • Non-enzymatic Dissociation Products
  • Instruments and Accessories

Global Cell Dissociation Market - By Tissue

  • Connective Tissue
  • Epithelial Tissue
  • Others

Global Cell Dissociation Market - By End user

  • Pharmaceutical and Biotechnology Companies
  • Research and Academic Institutes
  • Others

Global Cell Dissociation Market - By Region

  • North America
  • South America
  • Europe
  • Asia
  • Middle East & Africa

Table of Contents

1. Global Cell Dissociation Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Cell Dissociation Market - Market Definition and Overview

3. Global Cell Dissociation Market - Executive Summary

  • 3.1. Market Snippet by Product Type
  • 3.2. Market Snippet by Tissue
  • 3.3. Market Snippet by End User
  • 3.4. Market Snippet by Region

4. Global Cell Dissociation Market - Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Clinical laboratories are becoming more and more accredited to drive market growth.
    • 4.1.2. Restraints:
      • 4.1.2.1. Stringent quality-control regulations are expected to hamper market growth.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Cell Dissociation Market - Industry Analysis

  • 5.1. Supply Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Regulatory Analysis
  • 5.4. Unmet Needs

6. Global Cell Dissociation Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Cell Dissociation Market - By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type Segment
  • 7.2. Enzymatic Dissociation Products*
    • 7.2.1. Collagenase
    • 7.2.2. Trypsin
    • 7.2.3. Papain
    • 7.2.4. Elastase
    • 7.2.5. DNase
    • 7.2.6. Hyaluronidase
    • 7.2.7. Others
    • 7.2.8. Introduction
    • 7.2.9. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 7.3. Non-enzymatic Dissociation Products
  • 7.4. Instruments and Accessories

8. Global Cell Dissociation Market - By Tissue

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Tissue
    • 8.1.2. Market Attractiveness Index, By Tissue Segment
  • 8.2. Connective Tissue*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 8.3. Epithelial Tissue
  • 8.4. Others

9. Global Cell Dissociation Market - By End user

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 9.1.2. Market Attractiveness Index, By End user Segment
  • 9.2. Pharmaceutical and Biotechnology Companies*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 9.3. Research and Academic Institutes
  • 9.4. Others

10. Global Cell Dissociation Market - By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Tissue
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Tissue
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Tissue
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Tissue
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Tissue
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

11. Global Cell Dissociation Market - Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking
  • 11.4. List of Key Companies to Watch

12. Global Cell Dissociation Market- Company Profiles

  • 12.1. Merck KGaA*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Thermo Fisher Scientific
  • 12.3. Becton, Dickinson and Company
  • 12.4. F. Hoffmann-La Roche Ltd.
  • 12.5. Miltenyi Biotec
  • 12.6. PromoCell GmbH
  • 12.7. AcceGen
  • 12.8. Capricorn Scientific
  • 12.9. Neuromics
  • 12.10. Genlantis

LIST NOT EXHAUSTIVE

13. Global Cell Dissociation Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Applications
  • 13.3. Contact Us